Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: J Thromb Haemost. 2013 May;11(5):881–893. doi: 10.1111/jth.12176

Table 1.

Survival rate

Group N Survival (%) P
1 No treatment 20 7 (35) Reference
2 FVIII alone 17 15 (88.2) 0.001
3 FVIII + anti-IL-6R 15 15 (100) <0.001
4 FVIII + control IgG 10 9 (90) 0.008
5 Anti-IL-6R alone 20 8 (40) 0.492
6 Injured WT 10 10 (100) 0.002

Survival rate was evaluated on day 42 following the first injury. P values for significant difference compared to the “No treatment” group were calculated using log-rank test.